Contraindications and precautions Consider avoiding DSIP or consulting a physician if: Pregnant or breastfeeding (insufficient safety data) Taking naloxone or other opioid antagonists (may block effects) Using medications metabolized by peptidases (potential interactions) History of immune disorders (theoretical immunogenicity concern) Already using multiple sleep medications Drug interactions Because DSIP degrades via amino-peptidases in blood, medications affecting these enzymes (like the ACE inhibitor captopril) could theoretically alter DSIP metabolism
Description AOD9604 is a synthetic peptide fragment derived from the Cterminal end of human growth hormone (HGH 176191)
Taste: Glutathione contains sulfur, which gives it a distinct and often unpleasant sulfuric or eggy taste and smell
It looks at your genes, biochemistry, and lifestyle
Discover why this innovative peptide is becoming a preferred choice for research relating to: Tri-agonist targeting GLP-1, GIP, and glucagon Weight management Insulin sensitivity and glucose control Metabolic efficiency Additional Information Retatrutide has shown promising results in human trials
Stored at -80C for 1 year from date of receipt